Avicanna (TSX:AVCN) FCF Yield % : 0.76 (As of Jun. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Avicanna FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Avicanna's Trailing 12-Month Free Cash Flow is C$0.18 Mil, and Market Cap is C$23.99 Mil. Therefore, Avicanna's FCF Yield % for today is 0.76%.

The historical rank and industry rank for Avicanna's FCF Yield % or its related term are showing as below:

TSX:AVCN' s FCF Yield % Range Over the Past 10 Years
Min: -134.3 Med: -35.33 Max: 0.85
Current: 0.76

During the past 8 years, the highest FCF Yield % of Avicanna was 0.85%. The lowest was -134.30%. And the median was -35.33%.

TSX:AVCN's FCF Yield % is ranked better than
55.97% of 1081 companies
in the Drug Manufacturers industry
Industry Median: -0.16 vs TSX:AVCN: 0.76

Avicanna's FCF Margin % for the quarter that ended in Mar. 2024 was 1.15%.

Avicanna FCF Yield % Historical Data

The historical data trend for Avicanna's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avicanna FCF Yield % Chart

Avicanna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-46.70

-33.32

-34.79

-24.41

-6.18

Avicanna Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-23.67	-21.18	24.14	-11.32	0.61

Competitive Comparison of Avicanna's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Avicanna's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avicanna's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avicanna's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Avicanna's FCF Yield % falls into.

Avicanna FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Avicanna's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.962	/	31.73695
	=	-6.18%

Avicanna's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.074	*	4	/	48.151948
	=	0.61%

Avicanna FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Avicanna FCF Yield % Related Terms

Thank you for viewing the detailed overview of Avicanna's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avicanna (TSX:AVCN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avicanna Inc (TSX:AVCN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

AVCNF:USA 0NN:Germany

Address

480 University Avenue, Suite 1502, Toronto, BC, CAN, M5G 1V2

Website

https://www.avicanna.com

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Executives

Sheldon Inwentash

10% Security Holder

Avicanna (TSX:AVCN) Headlines

No Headlines